Avycaz
FDA approves first paediatric treatment for intra-abdominal and urinary tract infections in over 10 years
March 19, 2019Manufacturing and Production, Sales and Marketing Allergan, Avycaz, FDA, pharma
Allergan has revealed that Avycaz (ceftazidime and avibactam) has been awarded an expansion of its label by the FDA to include …
Top Ten most popular articles on Pharmafile.com this week
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma
It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
Allergan’s Avycaz becomes first FDA-approved gram-negative antibiotic in over 15 years
February 2, 2018Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia
Allergan has announced that the FDA has awarded approval to its fixed-dose combination antibacterial Avycaaz (ceftazidme and avibactam) for the …
FDA approves expanded label for Allergan’s Avycaz
June 24, 2016Medical Communications, Research and Development, Sales and Marketing Allergan, Avycaz, FDA, expanded label
Allergan (NYSE: FDA) has announced that the US Food and Drug Administration (FDA) has approved its supplemental new drug application …
Actavis and AZ see FDA approval for ‘superbug’ drug
February 27, 2015Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam
Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
